TET2突变的克隆血构增强了巨细胞抗原的呈现,并改善了固体瘤的免疫检查点治疗
Shelley Herbrich1, Mehdi Chaib2, Swetha Anandhan3
1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cancer cell
|October 17, 2025
概括
在骨髓细胞中具有TET2突变的克隆造血 (CH) 增强了抗瘤免疫力. 这一发现表明,TET2突变CH可能会预测固体瘤对免疫检查点治疗 (ICT) 的更好的反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 克隆性血液形成 (CH) 在癌症患者中很常见,但其在瘤免疫学和对免疫检查点治疗 (ICT) 的反应中的作用尚不清楚.
- Tet2突变在CH中很常见,并且影响髓状细胞功能.
研究的目的:
- 调查Tet2-突变CH在瘤免疫学和对ICT的反应中的作用.
- 探索Tet2-突变髓状细胞与抗瘤免疫之间的机制性联系.
主要方法:
- 利用一只老鼠骨髓模拟模型的Tet2-突变CH与固体瘤.
- 分析了非小细胞肺癌和结肠直肠腺癌患者的人类队列.
- 在瘤微环境中研究了巨细胞功能和T细胞原始化.
主要成果:
- 在瘤微环境中丰富的tet2-突变骨髓细胞在小鼠中改善了ICT反应.
- 泰特2突变巨细胞作为免疫原抗原呈现细胞,增强CD8+T细胞的原始化.
- 在接受ICT治疗肺癌和结直肠癌的人类患者中,TET2突变CH与改善的结局相关.
结论:
- 二突变CH通过巨细胞增强的抗原呈现,在塑造抗瘤免疫力方面发挥作用.
- TET2突变CH是一种潜在的预测生物标志物,用于改善实体瘤对ICT的反应.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:22T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K